前列腺癌的代谢景观
本文综述了前列腺癌(PC)相关的代谢改变及潜在诊疗机会。2018年3月检索PubMed/Medline,纳入50篇文献,按脂肪酸与胆固醇代谢(28项)、一碳代谢(9项)、氨基酸代谢(6项)和葡萄糖代谢(7项)分组。代谢改变在前列腺癌发生、进展和治疗抵抗中起关键作用,新型代谢特征可用于诊断和发现克服去势抵抗的治疗干预。
要点
- 脂肪酸与胆固醇代谢相关研究28项,为一碳代谢(9项)、氨基酸代谢(6项)和葡萄糖代谢(7项)以外最多的分组。
- 代谢改变可导致蛋白脂化、 oncogene激活、DNA甲基化、细胞信号传导和蛋白-蛋白相互作用中至少一种变化。
- 不断增加的代谢重编程知识正在揭示前列腺癌的新型代谢特征,可用于诊断和发现克服去势抵抗的新型治疗干预。
核心结论
- 代谢改变在前列腺癌发生、进展和治疗抵抗中起关键作用。
- 对代谢重编程的认识不断增加,正在揭示前列腺癌的新型代谢特征,这些特征可用于诊断以及发现克服去势抵抗的新型治疗干预。
研究设计与样本
- 2018年3月对PubMed/Medline进行综述,检索前列腺癌与以下每个检索词的关联:代谢组学;脂质、胆固醇、一碳、氨基酸和葡萄糖代谢。
- 共选取50篇出版物纳入本分析。
- 纳入报告按脂肪酸与胆固醇代谢(28项研究)、一碳代谢(9项研究)、氨基酸代谢(6项研究)和葡萄糖代谢(7项研究)分组。
主要发现
- 报告了前列腺癌中多种失调的代谢途径。
- 代谢改变可导致以下变化中的至少一种:蛋白脂化、 oncogene激活、DNA甲基化、细胞信号传导和蛋白-蛋白相互作用。
- 脂肪酸与胆固醇代谢相关研究28项,一碳代谢9项,氨基酸代谢6项,葡萄糖代谢7项。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Neoplastic cells are characterized by metabolic alterations that sustain tumor growth. Interventions aimed at modifying metabolic rewiring of cancer cells are currently being investigated in several tumor types, including prostate cancer (PC). OBJECTIVE: To review relevant metabolic alterations reported for PC and potential diagnostic and therapeutic opportunities that could be exploited on the basis of these discoveries. EVIDENCE ACQUISITION: We performed a review of PubMed/Medline in March 2018 for PC in association with each of the following search terms: metabolomics; lipid, cholesterol, one-carbon, amino acid, and glucose metabolism. Fifty publications were selected for inclusion in this analysis. EVIDENCE SYNTHESIS: The reports included were grouped according to fatty acid and cholesterol metabolism (28 studies); one-carbon metabolism (9 studies); amino acid metabolism (6 studies); and glucose metabolism (7 studies). We report on multiple metabolic pathways that are dysregulated in prostate cancer. Metabolic alterations can result in at least one of the following changes: protein lipidation, oncogene activation, DNA methylation, cellular signaling, and protein-protein interactions. CONCLUSIONS: Metabolic alterations play a crucial role in PC development, progression, and resistance to therapy. Increasing knowledge of metabolic rewiring is revealing novel metabolic signatures in PC. These signatures could be utilized for PC diagnosis, as well as for the discovery of novel therapeutic interventions to overcome castration resistance. PATIENT SUMMARY: Metabolic alterations play a crucial role in the development and progression of prostate cancer and its resistance to therapy. Our knowledge of metabolic rewiring is increasing and revealing novel metabolic signatures in prostate cancer. These signatures could be used for diagnosis and for the discovery of novel therapeutic interventions aimed at overcoming castration resistance.
引用
- Giunchi F, Fiorentino M, Loda M, et al. The Metabolic Landscape of Prostate Cancer. Eur Urol Oncol. 2018. PMID: 30929843. doi:10.1016/j.euo.2018.06.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。